Arkolith/Insider Trading/ALXN/Form 4

Orloff John J

EVP, Research & DevelopmentALEXION PHARMACEUTICALS, INC. (ALXN) · full profile →Form 4 · filed Jul 16, 2021
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
2
2 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jul 14, 2021Grant(A)30K—$0147K
Jul 14, 2021Grant(A)31K—$0117K

Transaction Codes

A
Grant / award

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0000899866-21-000054) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML